Skip to Content

Sugi Holdings Co Ltd SGIPF

Rating as of

Morningstar’s Analysis

Currency in USD
Is it the right time to buy or sell?
Find out with Morningstar Premium
Is it the right time to buy or sell?
Find out with Morningstar Premium

1-Star Price


5-Star Price


Economic Moat


About Quantitative Ratings

Morningstar Quantitative ratings for equities (denoted on this page by) are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies withratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating. Click here for more on how to use these ratings.

Company Profile

Business Description

Sugi Holdings Co Ltd generates revenue through pharmaceutical care in Japan. The company's drug stores sell prescription and generic drugs along with general merchandise including premium and discount groceries, discount cosmetics, pet supplies, and health supplements that are designed for self-medication. Sugi Holdings also provides disease prevention and drug delivery services. The company's Cedar Pharmacy group operates regional drugstores designed for providing health consultation. Sugi Holdings also supports regional healthcare facilities and provides at-home nursing services.

1-8-4 Mikawaanjo-cho
Anjo-shi, Japan
Sector Healthcare
Industry Pharmaceutical Retailers
Most Recent Earnings Nov 30, 2020
Fiscal Year End Feb 28, 2020
Stock Type
Employees 16,464